Director, China Program And Portfolio Management

Structure Therapeutics develops life‐changing medicines for patients using advanced structure‐based and computational drug discovery technology. The company’s platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs. We are advancing a clinical‐stage pipeline of differentiated treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic, and pulmonary conditions.

Structure Therapeutics is led by an experienced group of international drug innovators and financed by top-tier global life sciences investors. The company has completed an initial public offering (IPO) in February of 2023. With offices in California and Shanghai, Structure Therapeutics has the benefit of being at the center of life science innovation in both the US and China and capitalizing on the strengths of each geographic location.

Position Summary

This position is responsible for building the PPM capacity to support program teams in China. This individual will partner closely with program leaders to manage discovery programs to achieve corporate goals. As a single-point-of-contact with the clinical PM team in US, this individual will contribute to develop the integrated development plan and facilitate a smooth program leadership transaction from preclinical to clinical.  This individual will also contribute to China development strategy for clinical asset.   

Essential Duties and responsibilities

• Partnering closely with PLs to manage discovery programs to achieve corporate goals

• Facilitate the project governance process for key decision gates in the discovery programs, including scenario plannings, risk/benefit evaluations and team recommendations. Ensure decisions made in project governance are communicated to program team members and reflected in plans / timelines

• Responsible to develop and maintain discovery program plans and proactively manage program level risks

• Facilitate program meetings, agenda, minutes, action & decision logs, risk registers, etc.

• Set close link with clinical teams through PPM line to ensure the development of an integrated development plan for assets moving from preclinical phase to clinical

• Develop and maintain PPM process and tools for discovery programs, for example template for governance meeting materials, candidate selection document template, etc.

• Facilitate the evaluations of China clinical development strategy & plans for clinical asset. Responsible to drive the discussion cross-functionally within the organization or with external consultants / CROs and propose to governance the scenarios & recommendations

• Support FP&A in budgeting process

REQUIREMENTS

• At least 12 years of experience working in one or more functional roles in pharmaceutical development, with >5yrs in a cross-functional project management role.
• Experience in both early discovery program and (China) clinical development preferred.
• Experience in managing external CRO for China clinical study preferred
• Independent creative thinker able to challenge concepts
• Team player able to partner with different line functions
• Demonstrated ability to work in a dynamic and high-paced environment
• Solid understanding of the drug discovery and development processes with knowledge of appropriate regulatory guidelines
• Strong interpersonal and influential skills
• Excellent verbal and written communication skills